News

Published on 4 May 2024 on Insider Monkey via Yahoo Finance

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2024 Earnings Call Transcript

Article preview image

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2024 Earnings Call Transcript May 3, 2024

Amneal Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.29824 EPS, expectations were $0.09. Amneal Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Read the rest of the article
NYSE.AMRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Amneal Pharmaceuticals Inc (AMRX) Q3 2024 Earnings Call Highlights: Strong...

Release Date: November 08, 2024 For the complete transcript of the earnings call, please refer to...

GuruFocus.com · via Yahoo Finance 10 Nov 2024
Generic Drug-Focused Amneal Beats Q3 Expectations, Reaffirms Annual Forecasts

On Friday, Amneal Pharmaceuticals Inc (NASDAQ:AMRX) reported third-quarter adjusted EPS of $0.16,...

Benzinga · via Yahoo Finance 8 Nov 2024
Earnings To Watch: Amneal Pharmaceuticals Inc (AMRX) Reports Q3 2024 Result

Amneal Pharmaceuticals Inc (NASDAQ:AMRX) is set to release its Q3 2024 earnings on Nov 8, 2024. T...

GuruFocus.com · via Yahoo Finance 7 Nov 2024
Amneal Pharmaceuticals Inc (AMRX) Q2 2024 Earnings Call Highlights: Strong...

Q2 Revenue: $702 million, a growth of 17%. Generics Net Revenue: $427 million, up 14%. Biosimilar...

GuruFocus.com · via Yahoo Finance 11 Oct 2024
Insider Sale at Amneal Pharmaceuticals Inc (AMRX): Executive Vice President...

The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns...

GuruFocus.com · via Yahoo Finance 24 Aug 2024
Insider Sale at Amneal Pharmaceuticals Inc (AMRX) by Executive Vice President...

Following this transaction, the insider now owns 256,670 shares of Amneal Pharmaceuticals Inc....

GuruFocus.com · via Yahoo Finance 8 Aug 2024
Insider Sale: Director Deborah Autor Sells 38,000 Shares of Amneal Pharmaceuticals Inc (AMRX)

On May 17, 2024, Deborah Autor, Director at Amneal Pharmaceuticals Inc (NASDAQ:AMRX), executed a ...

GuruFocus.com via Yahoo Finance 22 May 2024
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2024 Earnings Call Transcript

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2024 Earnings Call Transcript May 3, 2024 Amneal Phar...

Insider Monkey via Yahoo Finance 4 May 2024
Drugmaker Amneal agrees to $270 million U.S. opioid settlement

, opens new tab said on Friday it had reached a deal valued at more than $270 million to resolve...

Reuters 3 May 2024
Amneal stock climbs on Q1 report, opioid settlement update (NASDAQ:AMRX)

Amneal (AMRX) stock climbed 9% Friday after the drugmaker released its Q1 earnings report and sai...

Seeking Alpha 3 May 2024

Copyright Statfolio @ 2024

Social Accounts